Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy of calcium gluconate infusion versus
cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in patients
pretreated with GnRH agonist long protocol who are at high risk for OHSS.